Bedaquiline Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials

PanACEA - STEP2C -01
Conditions:   Pulmonary Tuberculosis;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: Sutezolid;   Drug: Rifampicin;   Drug: Isoniazid;   Drug: Pyrazinamide;   Drug: Moxifloxacin;   Drug: Bedaquiline;   Drug: Delamanid Sponsors:   Michael Hoelscher;   Radboud University Medical Center;   University of California, San Francisco;   University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2023 Category: Research Source Type: clinical trials

PanACEA - STEP2C -01
Conditions:   Pulmonary Tuberculosis;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: Sutezolid;   Drug: Rifampicin;   Drug: Isoniazid;   Drug: Pyrazinamide;   Drug: Moxifloxacin;   Drug: Bedaquiline;   Drug: Delamanid Sponsors:   Michael Hoelscher;   Radboud University Medical Center;   University of California, San Francisco;   University College, London Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2023 Category: Research Source Type: clinical trials

Short-course Regimens for the Treatment of Pulmonary Tuberculosis
Conditions:   Tuberculosis, Pulmonary;   Tuberculosis Infection Interventions:   Drug: Rifabutin;   Drug: Delamanid;   Drug: Bedaquiline;   Drug: Moxifloxacin;   Drug: Pyrazinamide;   Drug: Isoniazid;   Drug: Rifampin;   Drug: Ethambutol Sponsors:   Centers for Disease Control and Prevention;   Tuberculosis Trials Consortium Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2023 Category: Research Source Type: clinical trials